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Redistribution of specialized molecules in migrating cells develops
asymmetry between two opposite cell poles, the leading edge and
the uropod. We show that acquisition of a motile phenotype in T
lymphocytes results in the asymmetric redistribution of ganglioside
GM3- and GM1-enriched raft domains to the leading edge and to the
uropod, respectively. This segregation to each cell pole parallels the
specific redistribution of membrane proteins associated to each raft
subfraction. Our data suggest that raft partitioning is a major deter-
minant for protein redistribution in polarized T cells, as ectopic
expression of raft-associated proteins results in their asymmetric
redistribution, whereas non-raft-partitioned mutants of these pro-
teins are distributed homogeneously in the polarized cell membrane.
Both acquisition of a migratory phenotype and SDF-1a-induced che-
motaxis are cholesterol depletion-sensitive. Finally, GM3 and GM1
raft redistribution requires an intact actin cytoskeleton, but is insen-
sitive to microtubule disruption. We propose that membrane protein
segregation not only between raft and nonraft domains but also
between distinct raft subdomains may be an organizational principle
that mediates redistribution of specialized molecules needed for T cell
migration.
Cell movement across a two-dimensional substrate requires adynamic interplay between attachment at the cell front and
detachment at the rear cell edge, combined with a traction ma-
chinery that pulls the net cell body forward. As adhesion and
detachment occur at opposite cell edges, the moving cell must
acquire and maintain spatial and functional asymmetry, a process
called polarization (1, 2). This asymmetry develops between two
opposite cell edges—the leading edge, which protrudes, and the
rear (termed uropod in lymphocytes), which retracts.
Because of the specialized functions of these compartments, each
pole in migrating cells is enriched in specific receptors and signaling
molecules but lacks others. In fibroblast-like cells and lymphocytes,
the leading edge contains chemokine receptors, several glyco-
sylphosphatidylinositol-linked proteins, such as the urokinase plas-
minogen activator receptor (uPAR), as well as the machinery that
senses the environment and induces localized actin polymerization
(1). Whereas the rear edge in fibroblasts appears to be a passive tail,
the lymphocyte uropod is a specialized pseudopod-like projection
with important functions, including motility and recruitment of
bystander cells. Several intercellular adhesion molecules (ICAMs)
concentrate at the uropod, including ICAM-1, -2 and -3, CD43,
CD44, as well as the actin-binding proteins of the ezrin–radixin–
moesin family. In accordance with its importance in lymphocyte
migration, crosslinking of molecules located in the uropod is
sufficient to trigger neutrophil polarization and motility (3).
To understand polarization and chemotaxis processes, the mo-
lecular mechanisms involved in the generation and maintenance of
the asymmetric distribution of cell-surface components must be
elucidated. Several lines of evidence suggest that association of
proteins with cholesterol- and glycosphingolipid-enriched raft-
membrane domains is crucial in distributing specialized molecules
to the leading edge of fibroblast-like migrating cells. The raft
marker GM1 ganglioside, the raft-associated chemokine receptor
CCR5, and other raft-associated proteins accumulate preferentially
at the leading lamella of migrating cells (4). Modification of
raft-located proteins such that they no longer associate with rafts
inhibits their asymmetric redistribution. The functional role of
asymmetric raft redistribution is shown in this article, as membrane
cholesterol depletion impairs cell polarization and chemotaxis.
Cholesterol-depleted cells showed isotropic pseudopodial protru-
sion, suggesting that raft redistribution is needed for location-
specific induction of pseudopod protrusion during cell polarization.
Moreover, rafts are the preferred cell platforms for membrane-
linked actin polymerization by in situ phosphatidylinositol 4,5-
bisphosphate synthesis and tyrosine kinase signaling through the
WASP-Arp2y3 pathway (5–7).
Raft association seems to be pivotal for protein redistribution to
the leading edge in migrating cells. To analyze whether this process
is a general mechanism in all cell types, we studied redistribution of
raft-associated membrane receptors and lipids during T cell polar-
ization, and found that membrane rafts are redistributed asym-
metrically in migrating T lymphocytes. In contrast to the exclusive
leading-edge redistribution detected in fibroblast-like cells, polar-
ized T lymphocytes segregate leading-edge and uropod markers
into two raft types that differ in lipid and protein composition.
Leading-edge rafts, characterized by including chemokine recep-
tors and uPAR, are enriched in GM3 ganglioside and devoid of
GM1; uropod rafts, containing CD44 and other cell-adhesion
molecules, are enriched in GM1 but lack GM3.
Ectopic expression of the raft-associated influenza virus hem-
agglutinin (HA) results in its asymmetric distribution in polarized
T cells, whereas expression of a nonraft mutant version (HA2A520;
ref. 8) results in homogeneous protein distribution on the cell
membrane. We observed asymmetrical redistribution of a green
fluorescent protein (GFP)-tagged version of the vesicular stomatitis
virus glycoprotein (VSVG3)-GFP (9) that colocalizes with GM1
when expressed in T cells. A mutant version of this protein
(VSVG3-SP-GFP; ref. 10), which does not colocalize with GM1, is
distributed homogeneously on the cell membrane. These data
suggest that raft partitioning is a major determinant of asymmetric
protein redistribution in polarized T cells. Accordingly, membrane
cholesterol depletion impedes acquisition of a polarized cell phe-
notype and inhibits both cell–cell interaction and cell chemotaxis.
All together, the results indicate a prominent role for membrane
rafts in the acquisition of the polarity needed for T cell chemotaxis.
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Materials and Methods
Cell Culture, Expression Constructs, and Antibodies. The murine NS-1
T cell hybridoma and the human Jurkat cell line were cultured in
RPMI medium 1640 with 5% (volyvol) FCS, antibiotics, L-
glutamine, and sodium pyruvate. The influenza virus HA wild type
and the HA2A520 mutant, with two point mutations in the
transmembrane domain that reduce raft association (8), were a gift
of P. Scheiffele (Univ. of California, Berkeley). VSVG3-GFP and
VSVG3-SP-GFP (9, 10), which is identical to VSVG3-GFP but has
a spacer between the viral protein and the GFP moiety, were given
by P. Keller (Max Planck Institute, Molecular Cell Biology and
Genetics, Dresden, Germany). All constructs were subcloned into
the pLZR retroviral vector; NS-1 cells were transduced with the
recombinant retrovirus (11).
Surfact-Amps X-100 with 10% (volyvol) Triton X-100 and
Surfact-Amps 58 with 10% (volyvol) Brij58 were obtained from
Pierce. Optiprep gradient medium was obtained from Nycomed
Pharma, latrunculin-B from Calbiochem, and methyl-b-cyclodex-
trin (CD), demecolcine, water-soluble cholesterol, filipin III, fi-
bronectin, BSA, peroxidase (PO)-conjugated streptavidin, biotin-
and FITC-labeled cholera toxin b-subunit (CTx), and anti-talin
monoclonal antibody (mAb) were obtained from Sigma. Anti-
CXCR4 (Fab172B) and anti-human CD44 mAb were obtained
from R & D Systems, rat anti-mouse CD44 and biotin-labeled
anti-human CD43 from PharMingen, anti-mouse CD43 from Santa
Cruz Biotechnology, and anti-transferrin receptor from Zymed.
Rabbit anti-HA was a gift of P. Scheiffele, and PO- or Cy3-labeled
secondary antibodies were obtained from Dako or Jackson
ImmunoResearch.
Characterization of Anti-GM3 Antiserum. A serum sample from a
patient with acute polyneuropathy was analyzed for IgM and IgG
antibodies to GM1, GM2, GM3, aGM1, GD1a, GD1b, GD3,
GT1b, and GQ1b by direct ELISA and TLC. ELISA titers were
calculated by end-point dilution analysis of optical densities. For
TLC, 1 mg per lane of each lipid was loaded onto a silica gel plate
and developed by using a methanol, chloroform, and CaCl2 solvent.
After blocking with PBSyBSA, each plate was covered with 2.5 ml
of diluted test serum (1y100) and incubated for 4 hr at 4°C. After
washing, plates were incubated for 1 hr at 20°C with PO-conjugated
IgM or IgG, as required. Serum reactivity to crude cell extracts (20
mg per lane) was analyzed by Western blotting.
Flotation Experiments. To analyze detergent-insoluble complexes in
flotation gradients, 15 3 106 Jurkat cells stimulated with SDF-1a
(100 nM, 15 min, 37°C; PeproTech, Rocky Hill, NJ) were cooled on
ice, washed with PBS, and lysed in 300 ml of TNE buffer (50 mM
TriszHCl, pH 7.4y150 mM NaCly5 mM EDTA) with 0.5% Triton
X-100 or 1% Brij58. Cells were extracted for 20 min on ice and the
extract was subsequently brought to 35% (volyvol) Optiprep.
One-third of the lysate was sequentially overlayered with 3.5 ml of
30% (volyvol) Optiprep and 200 ml of TNE with detergent in an
SW60 tube. After centrifugation (4 hr at 170,000 3 g at 4°C), five
fractions were collected from the gradient (top to bottom) and
precipitated with trichloroacetic acid. Normalized protein amounts
for each fraction were analyzed by SDSyPAGE and Western
blotting.
For cholesterol depletion, serum-starved Jurkat cells were incu-
bated with 5 mM CD for 30 min at 37°C. Under these conditions,
CD treatment does not induce cell detachment from the substrate
or modify viability (data not shown). After incubation, CD was
removed by repeated washing with serum-free medium containing
0.01% BSA, then cells were stained with filipin as described (4).
Flotation gradients of untreated and CD-treated cells were pre-
pared as above.
Immunofluorescence and Antibody-Induced Patching. Resting pe-
ripheral blood lymphocytes (PBLs) were isolated from fresh human
blood by Ficoll–Hypaque density-gradient centrifugation (Amer-
sham Pharmacia), then plated in two adherence incubation steps at
37°C for 1 hr each in plastic flasks, then plated on recombinant
human ICAM-2yFc chimera protein (R & D Systems). NS-1 and
Jurkat cells were plated on fibronectin (Fn)-coated eight-well-
chamber glass slides 24 hr before assay. Serum-starved Jurkat cells
and PBLs were stimulated with 100 nM SDF-1a, then washed and
fixed with 3.7% (wtyvol) paraformaldehyde for 5 min on ice in PBS.
Samples were incubated with the indicated antibodies, then with
Cy2- or Cy3-conjugated second antibodies for 45 min on ice. For
talin-staining, methanol-permeabilized cells (10 min, 220°C) were
blocked with PBSy2% (wtyvol) BSA for 1 hr at 4°C before staining
with primary antibodies. Slides were mounted in Vectashield
medium containing 49,6-diamidino-2-phenylindole (Vector Labo-
ratories). In some experiments, NS-1 cells plated on Fn were treated
at 37°C for 30 min with 10 mM latrunculin-B or 0.3 mM demecol-
cine, washed twice with medium, and fixed and stained with
FITC-CTx and anti-CD44 or anti-GM3.
For HA and HA2A520 visualization in transduced NS-1 cells,
antibody-mediated lateral copatching was performed by incubating
unfixed cells for 30 min at 12°C with anti-HA and anti-GM3
antibodies. Further crosslinking was performed with Cy2- and
Cy3-second antibody for 30 min at 12°C; antibody–receptor com-
plex internalization was not seen. Cells were fixed and mounted as
above. For HA copatching with CTx, FITC-CTx (6 mgyml) was
added after fixation and incubated for 10 min at 4°C; cells were
methanol-fixed for 10 min at 220°C before mounting.
In all cases, cells were visualized by confocal laser scanning
microscopy. Linear signal intensity for each fluorophore was cov-
ered by a linear scale of pixel intensities. The two colors were
acquired separately and merged by using TCS NT software (Leica).
Digital images were processed with PHOTOSHOP (Adobe).
Polarization, Cell–Cell Interaction, and Chemotaxis of Cholesterol-
Depleted Cells. NS-1 cells were untreated or CD-treated as for
Jurkat cells. A portion of the CD-treated cells was incubated for 30
min at 37°C in RPMI 1640 medium with 60 mgyml free cholesterol.
Untreated, CD-treated, or cholesterol-replenished cells were fixed
with 3.7% (wtyvol) paraformaldehyde, then incubated with anti-
CD44. Polarization was analyzed by confocal and phase-contrast
microscopy.
For cell–cell interaction, Jurkat cells were untreated, treated with
CD, or treated with CD plus cholesterol, then plated on fibronectin-
coated chambers in the presence of SDF-1a (25 nM). After the
addition of PBLs (7.5 3 104 cells per well), images were acquired
in phase-contrast microscopy. Jurkat cells attached and spread on
the substrate (phase-dark cells), and PBLs that adhered to the
Jurkat cell uropod (phase-bright cells) were counted for each
condition. Recruitment index is expressed as PBLs captured di-
vided by the number of substrate-adhered Jurkat cells in the first
layer.
For chemotaxis, Jurkat cells were untreated or treated with CD
or CD plus cholesterol, resuspended, and migration-analyzed in a
modified Boyden chamber (Costar). In all cases, 2 3 105 cells in
serum-free medium were seeded in the upper chamber and the
lower chambers were filled with serum-free medium alone or
serum-free medium containing SDF-1a (25 nM). After incubation
for 2.5 hr at 37°C, the cell number in the lower chamber was
estimated by flow cytometry with an electronically programmable
individual cell sorter. The chemotactic index was calculated as the
quotient of the number of cells recovered in SDF-1a transwells and
the number of cells in the absence of stimulus.
Results
GM1-Based Rafts Are Asymmetrically Distributed to the Migrating T
Cell Uropod. We analyzed whether lipid rafts are asymmetrically
redistributed in polarized T cells, as reported for fibroblast-like
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cells, by studying raft-enriched ganglioside GM1 distribution in
constitutively polarized NS-1 cells. When plated on fibronectin,
most NS-1 cells become polarized with a well defined leading edge
and uropod. Compared with the homogeneous distribution in
nonpolarized cells (data not shown), GM1 concentrated mainly at
the NS-1 cell uropod, as determined by morphological criteria and
by colocalization studies with uropod-specific markers such as
CD44 (Fig. 1A). GM1 also appears at the edge opposite that at
which leading-edge markers such as talin (12) are seen, confirming
GM1 concentration at the NS-1 cell uropod (Fig. 1B).
It was unclear whether uropod GM1 concentration is unique to
NS-1 cells or is a generalized phenomenon in polarized T cells.
Therefore, we analyzed GM1 distribution in Jurkat cells stimulated
with SDF-1a, a chemokine that induces CXCR4 redistribution to
the leading edge of migrating Jurkat cells (13). GM1 patches
redistribute to and colocalize with the uropod marker CD44 (Fig.
1C) but segregate to the pole opposite the CXCR4 staining (Fig.
1D). Collectively, these results indicate that GM1-based rafts and
their associated proteins are distributed to the uropod in T cells with
a migrating phenotype.
Leading-Edge Proteins in Migrating T Cells Colocalize with GM3-Rafts.
Chemokine receptors such as CXCR4 partition into the raft
fraction (14, 15), although CXCR4 does not colocalize with GM1
in T cells (Fig. 1D). Some glycosylphosphatidylinositol-anchored
leukocyte-surface glycoproteins that accumulate at the leading
edge associate preferentially to GM3 (16), suggesting that GM3-
based rafts concentrate at the leading-cell edge. We analyzed GM3
distribution in migrating cells by using an antiserum from a patient
with acute polyneuropathy with a high anti-GM3 titer (1y740) but
no reactivity to a battery of other gangliosides including GM1. In
addition, this antiserum does not react with cell proteins as analyzed
by Western blotting (data not shown).
GM3 is asymmetrically distributed, forming patches at the same
pole as talin (Fig. 2A) and colocalizing with other leading-edge
markers such as CXCR4 (Fig. 2B) and uPAR (Fig. 2C). GM3
concentrates mainly at the edge opposite that of GM1 (Fig. 2D),
which decorates the uropod (see above). These results indicate the
existence of two distinct raft types in T cells, which segregate to
opposite sides once the cell acquires a migrating phenotype; GM3-
enriched rafts redistribute to the leading edge, and GM1-enriched
rafts concentrate at the uropod. Segregation between leading rafts
(L-rafts) and uropod rafts (U-rafts) is also seen in freshly isolated
SDF-1a-stimulated PBLs; GM1 colocalizes with the uropod
marker CD44 (Fig. 2E), and GM3 colocalizes with the leading-edge
marker CXCR4 (Fig. 2F).
GM1- and GM3-Raft-Associated Proteins Partition in Detergent-Resis-
tant Membranes. Raft-associated membrane proteins float in den-
sity gradients as detergent-resistant membranes (DRM; ref. 17);
this property distinguishes them from insoluble complexes formed
by cytoskeletal association. To analyze DRM partitioning of GM1-
and GM3-associated proteins, we fractionated Jurkat cells lysed
with the nonionic detergents Triton X-100 and Brij58. The leading-
edge markers CXCR4, uPAR, and GM3, as well as the uropod
markers CD44 and GM1, partition to the DRM fraction indepen-
dently of the detergent used (Fig. 3A). Triton X-100 and Brij58
Fig. 1. GM1-rafts concentrate at the uropod of migrating T cells. NS-1 (A and
B) or SDF-1a-stimulated Jurkat cells (C and D) were costained with CTx to reveal
GM1 (green), with leading edge or uropod markers indicated (red), and analyzed
by confocal microscopy. Fluorescence is shown for each signal and for the merg-
ing of both; colocalization is seen as yellow. To visualize cell shape (Left), laser
power was saturated for green and red channels. These cells are representative
of the majority of cells recorded in independent experiments. (Bar 5 2 mm.)
Fig. 2. GM1- and GM3-rafts segregate to opposite cell edges in T cells. Confocal
analysis of NS-1 (A and D), SDF-1a-stimulated Jurkat cells (B and C), and SDF-1a-
stimulated PBLs (E and F) costained with anti-GM3 antiserum or CTx and with
various leading-edge and uropod markers, as indicated. For NS-1 and Jurkat cells,
fluorescence for each channel and the merging of both signals are shown,
whereas only merging is displayed for PBLs; colocalization of the signals is seen as
yellow. (Bar 5 2 mm.)
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differ in their hydrophilic-lipophilic balance, a characteristic used to
distinguish raft types in Madin–Darby canine kidney (MDCK) cells
(18). Although Brij58 increases DRM-associated proteins and
lipids, no differential solubility was detected between GM3- and
GM1-associated markers in using the two detergents. Full solubi-
lization of nonraft proteins such as the transferrin receptor confirms
the quality of the fractionations.
CD treatment of Jurkat cells to sequester membrane cholesterol
before fractionation resulted in increased CXCR4, uPAR, and
CD44 solubility with either detergent (Fig. 3B). This result suggests
that leading-edge and uropod-marker association to L- or U-rafts
is sensitive to cholesterol extraction, although differences in cho-
lesterol content for each raft type cannot be excluded.
Raft Association Is Needed for Membrane Protein Redistribution. We
examined whether protein redistribution to the leading edge of the
uropod is a consequence of specific association to GM3- or
GM1-enriched rafts. NS-1 cells were transduced with retrovirus
coding for the raft-associated influenza virus HA protein and the
nonraft HA2A520 mutant (8). These cells were also transduced
with two GFP-tagged versions of VSVG (VSVG3-GFP and
VSVG3-SP-GFP). VSVG colocalizes with GM1 in several cell
types, although it does not partition in DRM (19). Accordingly,
neither VSVG3-GFP nor VSVG3-SP-GFP partition in DRM, but
only VSVG3-GFP colocalizes with GM1 (see Fig. 4 A and E). The
differential behavior of VSVG3-GFP and VSVG3-SP-GFP is not
yet understood, although the masking of sorting signals in VSVG3-
GFP may be implicated (9).
HA and VSVG3-GFP redistribute to the uropod in polarized
NS-1 cells and colocalize with GM1 (Fig. 4 A and C) but segregate
from GM3 rafts (Fig. 4 B and D). HA and VSVG3-GFP proteins
probably do not associate to cytoskeleton or to other cell receptors;
thus, their preferential accumulation in the uropod is solely the
consequence of their U-raft association. Therefore, we expressed
the nonraft HA mutant (HA2A520) and the basolateral-sorted
VSVG3-SP-GFP and analyzed their distribution in polarized NS-1.
HA2A520 or VSVG3-SP-GFP proteins were homogeneously dis-
tributed on the NS-1 cell surface with strong polarization of GM1
(Fig. 4 E and G) and GM3 (Fig. 4 F and H). Quantitative analysis
indicated that 85% of polarized, transduced NS-1 cells accumulated
HA and VSVG3-GFP proteins preferentially at the uropod,
whereas 14% of the NS-1 cells redistributed HA2A520 and
VSVG3-SP-GFP proteins to a single cell pole. This result indicates
that raft association is a major determinant for asymmetric protein
redistribution in T cells.
Functional Role of Rafts in Polarization and Chemotaxis. To address
the functional role of rafts in lymphocyte polarization, we studied
the effect of cholesterol depletion on the acquisition of a migrating
phenotype in NS-1 cells. Morphology and polarization marker
redistribution were analyzed in cholesterol-depleted cells. CD
treatment significantly reduces the number of NS-1 cells with a
polarized phenotype, as well as the asymmetric redistribution of
CD44 (Fig. 5 A and B). Cholesterol replenishment by incubating
CD-treated cells with free cholesterol (20) restores the number of
cells with a polarized phenotype (Fig. 5B), indicating that the CD
inhibitory effect is limited to cholesterol removal.
Next, we studied whether cholesterol depletion affects specific
uropod and leading-edge function. The ability to recruit bystander
T cells was used as an indicator of uropod performance. As for
polarization, CD treatment inhibits PBL recruitment to the Jurkat
cell uropod, which was restored by replenishing cholesterol (Fig.
5C). The effect of cholesterol depletion on leading-edge function
was tested by Jurkat cell chemotaxis toward SDF-1a, as CXCR4
localizes at this cell pole. CD treatment inhibited chemotaxis
toward this chemokine, whereas cholesterol replenishment restored
normal migration values (Fig. 5D). These data suggest a role for
rafts in bystander T cell recruitment and lymphocyte chemotaxis,
which require prior acquisition of a polarized phenotype.
Asymmetric U- and L-Raft Distribution Requires Intact Actin Cytoskel-
eton. Finally, we addressed the mechanism involved in raft redis-
tribution by disrupting actin (latrunculin-B) or microtubule (de-
mecolcine) cytoskeleton. Asymmetric distribution of GM1 and
GM3 lipids was abolished in latrunculin-B-treated cells (Fig. 6A)
but was preserved in demecolcine-treated cells (Fig. 6B). The actin
cytoskeleton-associated receptor CD44 (1) is also homogeneously
distributed in latrunculin-B-treated cells (Fig. 6C) but remains
asymmetrical in demecolcine-treated cells (Fig. 6D). It is interesting
to note that CD44 and GM1 colocalization is largely lost in
latrunculin-treated cells, suggesting that raft partitioning of CD44
Fig. 3. GM1- and GM3-associated molecules partition in cholesterol-sensitive
DRM. Jurkat cells were stimulated with SDF-1a, then left untreated (A) or CD-
treated (B). Cells were lysed in TNE buffer with Triton X-100 or Brij58 and
fractionated in Optiprep gradients. Fractions were collected from gradient top
(DRM) to bottom (detergent-soluble proteins and cytoskeleton) and analyzed by
Western blotting with the indicated antibodies; GM1 was detected with biotin-
ylated CTx. TfR, transferrin receptor.
Fig. 4. Raft association is a requisite for membrane protein redistribution in
polarized T cells. Distribution of VSVG3-GFP (A and B) or HA wild type (HAwt; C
and D), and of mutants VSVG3-SP-GFP (E and F) or HA2A520 (G and H) in NS-1 cells
was analyzed after copatching with anti-GM3 antibody or FITC-CTx, as indicated.
The panels show red and green signal overlay. In the case of VSVG3 (green), GM1
and GM3 are visualized in red; for HAwt (red), GM1 and GM3 are in green.
Colocalization is seen as yellow. The proportion of cells showing asymmetrical
distribution was calculated by direct counting (n 5 50–60) of transduced cells
with a polarized phenotype. (Bar 5 2 mm.)
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is regulated by the actin cytoskeleton. Collectively, these results
show that asymmetric distribution of both L- and U-rafts specifi-
cally require actin cytoskeleton integrity.
Discussion
In migrating, a cell must integrate spatial and temporal infor-
mation provided by environmental cues to correctly redistribute
membrane receptors, adhesion proteins, and signaling molecules
and to induce the cytoskeletal changes that lead to the polarized
phenotype. Nonetheless, the mechanisms that effect this polar-
ization are not fully understood. Asymmetry in constitutively
polarized cells such as epithelia and neurons is achieved in part
by sorting cargo proteins to specific membrane locations by using
two post-Golgi circuits, one independent of and one dependent
on protein clustering with lipid rafts (21). We have shown that
protein clustering in raft domains also is needed for their
redistribution to the leading edge of migrating adenocarcinoma
cells (4), suggesting that initial segregation between raft and
nonraft proteins in the trans-Golgi network may have a role in
inducing a migrating phenotype in initially nonpolarized cells.
Golgi integrity is required to generate and maintain cell asym-
metry and directed cell migration (11, 22).
Three major lines of evidence indicate that partitioning in raft
domains is pivotal in membrane protein distribution to specific
locations during lymphocyte polarization. First, raft-associated
proteins and lipids are asymmetrically distributed in T cells with a
migrating phenotype. Second, proteins with no functional signifi-
cance in cell polarization or migration segregate asymmetrically
in migrating lymphocytes as a function of their raft association,
and in addition, nonraft partitioned mutants are distributed
homogeneously in polarized cells. Third, membrane cholesterol
depletion impedes cell polarization and inhibits chemokine-
induced chemotaxis.
These results concur with and amplify the concept of membrane
rafts as necessary platforms for membrane receptor redistribution
and acquisition of a polarized phenotype during carcinoma cell
migration (4). Whereas GM1-enriched rafts accumulated at the
leading pseudopodia in tumor cells, we observed segregation of two
distinct types of raft domains that distribute to opposite edges in T
cells—the GM3-enriched leading edge (L-raft) and the GM1-
enriched uropod (U-raft). This difference between carcinoma cells
and T cells may reflect distinct migration strategies (23). In carci-
noma cells (as in fibroblasts), the leading edge consists of one or
several pseudopodia that attach to the substrate; integrins and other
adhesion receptors such as CD44 cluster prominently at the leading
pseudopod where F-actin also accumulates. Moreover, blockage of
cell-adhesion receptors with anti-integrin antibodies inhibits cell
polarization and migration, indicating that integrin-mediated cy-
toskeletal linkages are needed to trigger migration in these cells (24,
25). In contrast, the leading edge of migrating T cells is weakly
stained or negative for integrins and other adhesion receptors such
as CD44 and ICAM-1 and -3, which concentrate at the uropod.
Concurrently, focal adhesion kinase is phosphorylated and redis-
tributed to the leading edge (26), whereas F-actin stains the uropod
(27). This unique compartmentalization characterizes T cells as
bipolar sensors optimized for cell–cell (at the U-raft) and cell–
Fig. 7. Model for the redistribution of membrane rafts and associated proteins
in migrating T cells and fibroblast-like cells. The scheme shows the segregation of
U-rafts (GM1-enriched) and L-rafts (GM3-enriched) in migrating T cells, as well as
the predictive association of membrane receptors and signaling molecules to
each raft type, based on our results or those in literature (1, 36). In fibroblast-like
cells, both U- and L-rafts probably redistribute to the leading edge; see Discussion
for details. ERM, ezrin–radixin–moesin.
Fig. 5. Membrane rafts mediate the front–rear polarity required for T cell
function. (A) Membrane cholesterol depletion impairs cell polarization. Panels
show phase-contrast images (Upper) and CD44 distribution (Lower) of untreated
(Control), CD-treated (CD), and cholesterol-replenished (CD1Cho) NS-1 cells.
(Bar 5 10 mm.) Bars in B–D: untreated (2), CD-treated (CD), and cholesterol
replenished (CD1Cho). (B) Random fields (n 5 8) in two independent experi-
ments were recorded. Cells with a polarized phenotype (as determined by mor-
phology and CD44-polarization) were counted directly. Total cells recorded:
untreated, 250; CD-treated, 205; CD 1 Cho, 210. (C) Raft integrity is required for
bystander T cell recruitment. Untreated, CD-treated, and cholesterol-replenished
Jurkat cells were stimulated with SDF-1a and PBL recruitment was analyzed by
direct counting. Data are expressed as a recruitment index (see Materials and
Methods). (D) Cholesterol depletion inhibits cell chemotaxis. Untreated, CD-
treated, and cholesterol-replenished Jurkat cells were assayed for chemotaxis
toward SDF-1a. Cells in the lower chamber were recovered, and the number was
estimated by flow cytometry. The figure shows the chemotactic index, calculated
as described in Materials and Methods.
Fig. 6. Raft distribution requires intact actin cytoskeleton. NS-1 cells were
treatedwith latrunculin-B (AandB)ordemecolcine (CandD)andthedistribution
of GM1 and GM3 (A and C) or GM1 and CD44 (B and D) was analyzed by confocal
microscopy. Images are representative of cells recorded (n 5 40) in two indepen-
dent experiments. (Bar 5 2 mm.)
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matrix (at the L-raft) interactions (28). Thus, the T cell uropod
morphologically and functionally resembles the leading pseudo-
podia of fibroblast-like cells including GM1-enriched raft accumu-
lation at this cell pole. Accordingly, ezrin–radixin–moesin proteins
that link F-actin to the cytoplasmic tails of adhesion molecules
partition in GM1-enriched rafts (29) and redistribute to the leading
edge in fibroblasts (30) but redistribute to the uropod in lympho-
cytes (31).
There is also correspondence between leading-edge-redistrib-
uted molecules in fibroblast-like cells and T cells. Raft-associated
proteins such as chemokine receptors and uPAR redistribute to the
leading edge in migrating fibroblast-like cells (4, 32) and lympho-
cytes (1, 33). Different raft platforms are used—GM1 rafts in
fibroblast-like cells and GM3 rafts in T cells. Two distinguishable
GM3- and GM1-enriched raft subfractions also are reported in
nonlymphoid cells (34, 35): the GM3 rafts are enriched in specific
proteins such as FAK, Src family kinases, and the small Rho
GTPases (36), all of which concentrate at the leading edge of
migrating T cells (1). GM1- and GM3-enriched rafts may redis-
tribute to the same cell pole in fibroblast-like cells (37). Known L-
and U-raft markers are outlined in Fig. 7.
Asymmetric protein redistribution during polarization depends
on raft association rather than on their functional significance in cell
motility or signaling. A prominent role is reported for cytoskeletal
interactions in CD43, CD44, and ICAM-3 redistribution to the
uropod (1). VSVG3-GFP and HA are unlikely to associate with
cytoskeleton or interact with other T cell membrane proteins; thus,
their asymmetric redistribution may be caused by the coalescence
of laterally diffusing rafts in specific cell locations such as the
uropod. These results suggest that membrane receptor partitioning
to rafts may occur upstream of their linkage to cytoskeleton and
function as a mechanism for uropod redistribution. Nonetheless, an
intact actin (but not tubulin) cytoskeleton is needed for L- and
U-raft redistribution, concurring with other reports (38). Because
ezrin–radixin–moesin proteins partition to rafts, raft association of
CD43, CD44, and other adhesion receptors may favor their linkage
to the cytoskeleton for correct redistribution.
The physiological implications of raft coalescence for acquisition
of front–rear polarity and cell chemotaxis are evident, as it may
provide a mechanism for the integration of distinct signaling
pathways. That chemoattractant receptors partition in these do-
mains suggests that asymmetrical raft redistribution amplifies che-
motactic signal detection. The amplification may occur at the
receptor level or downstream through local activation of chemo-
tactic intermediates such as Rho GTPases and generation of
phosphatidylinositol 4,5-bisphosphate, found in raft domains and at
the leading edge of neutrophils (39). There is functional evidence
that raft clustering may activate local signal transduction; indeed,
compartmentalization of cell receptors and signaling molecules
between raft and nonraft membrane domains is required for
efficient antigen-mediated T cell activation (40).
In addition to the essential role of rafts as organizational prin-
ciples in T cell receptor signaling and immunological synapse
stabilization, we show that membrane rafts may also be a mecha-
nism for local activation of signaling pathways involved in the cell
asymmetries required for T cell migration.
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